Page 1

JAPAN AIRLINES Co. , Ltd. Financial Results 1st Quarter Mar / 2022 ( FY2021 ) JAPAN AIRLINES KGS KME COVID - 19 Vaccin Moderna 0.20 mg / ml , Dispersion for COVID - 19 mRNA Vac ( nucleoside modified muscular Use Date / Time : Multidose vial ( 10 doses of 0.5 mL ) FL - 57 JAL APAN AIRLINES P306STVO JAL JAPAN AIRLINES JAPAN AIRLINES va - tainer XL August 3 , 2021 © Japan Airlines , ALL rights reserved .